Safety & Efficacy of BCT197A2201 in Chronic Obstructive Pulmonary Disease (COPD) Patients Presenting With an Exacerbation
Status:
Completed
Trial end date:
2013-05-01
Target enrollment:
Participant gender:
Summary
This study will assess preliminary parameters of safety and efficacy of a single dose of
BCT197 in patients with a Chronic Obstructive Pulmonary Disease (COPD) exacerbation.